Log in to your Inderes Free account to see all free content on this page.
Modus Therapeutics Holding
0.45 SEK
+5.16 %
Less than 1K followers
MODTX
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Modus Therapeutics Holding
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| EBITDA | -3.0 | -4.9 | -15.8 | -2.7 | -5.9 | -4.2 | ||
| EBIT | -3.0 | -4.9 | -15.8 | -2.7 | -5.9 | -4.2 | -5.3 | -18.1 |
| EBIT-% | ||||||||
| Profit before taxes | -3.0 | -5.0 | -15.8 | -2.8 | -6.1 | -4.3 | -5.3 | -18.5 |
| Net income | -3.0 | -5.0 | -15.8 | -2.8 | -6.1 | -4.3 | -5.3 | -18.5 |
Login required
This content is only available for logged in users